China Feihe Ltd
HKEX:6186
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
China Feihe Ltd
EPS (Diluted)
China Feihe Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
China Feihe Ltd
HKEX:6186
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
EPS (Diluted)
¥1
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
EPS (Diluted)
¥1
|
CAGR 3-Years
3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
7%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
EPS (Diluted)
¥1
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
23%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
EPS (Diluted)
¥1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
China Feihe Ltd
Glance View
China Feihe Ltd., a distinguished player in the infant formula industry, traces its roots back to 1962, establishing itself as a pioneer in dairy production in China. Over the decades, the company has morphed from a state-run enterprise into a market leader, capturing the hearts of parents with its deep understanding of nutritional needs and local dietary preferences. Feihe's story is one of strategic evolution—building a robust supply chain, leveraging advanced research, and investing heavily in quality control. Their vertically integrated business model, from dairy farming and production to distribution, ensures a high standard of excellence. With an extensive product portfolio that covers multiple price points and consumer segments, Feihe caters to middle-class desires for health and premium quality, setting itself apart in a market characterized by growing competition and rising consumer expectations. In the bustling and competitive landscape of China's baby formula market, Feihe crafts its narrative by capitalizing on its '100% Made in China' ethos, assuring consumers of quality and safety—a paramount concern given past industry scandals. Operating through a sleek blend of strategic marketing and community trust-building, the company focuses on fostering customer loyalty and brand recognition. By employing state-of-the-art technology and innovation, Feihe develops products that align with the specific health requirements of Chinese infants. This includes formulas enriched with nutrients like DHA and ARA, mimicking the composition of breast milk, and featuring localized ingredients to ensure assimilation and growth. Feihe continues to elevate its brand by expanding its reach to international markets, signifying a forward-looking approach while remaining rooted in its profound local heritage.
See Also
What is China Feihe Ltd's EPS (Diluted)?
EPS (Diluted)
0.2
CNY
Based on the financial report for Dec 31, 2025, China Feihe Ltd's EPS (Diluted) amounts to 0.2 CNY.
What is China Feihe Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-24%
Over the last year, the EPS (Diluted) growth was -46%. The average annual EPS (Diluted) growth rates for China Feihe Ltd have been -27% over the past three years , -24% over the past five years .